Development of a new range of immunodiagnostic kits for the
rapid diagnosis of gonorrhoea infections.
Generation and selection of a complete, new panel of
inonoclonal antibodies to N. gonorrheal.
Incorporation of these into rapid acting and easily used
diagnostic kits which may involve novel clad-out
Equivalent products and this technology have not been
available to BIOKIT in the past.
Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.